Product Program year 2020 Source: CMS Open Payments

InPen

Device Continuous Glucose Monitoring

Open in the dashboard

General payments

$39,915,312

216 payments

Research payments

$0

0 payments

Through program year 2020, $39,915,312 in general payments and $0 in research payments were reported against InPen (Continuous Glucose Monitoring).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $39,915,312 216

Breakdown

Who paid General payments · program year 2020
  1. Medtronic MiniMed, Inc. $39,915,312 216 payments
Top recipients General payments · program year 2020
  1. Aaron Berez Neuroradiology · Mountain View, CA $20,008,738 50% · 6 payments
  2. Marshall Ching Oroville, CA $14,706,404 37% · 4 payments
  3. Brian Ching Oroville, CA $1,119,187 3% · 2 payments
  4. Bradley Ching Dentist, General Practice · Upland, CA $1,119,187 3% · 2 payments
  5. Peter Nelson Neuroradiology · New York, NY $663,667 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Neuroradiology Radiology $20,672,404 86% · 2 practitioners
  2. Dentist, General Practice Dentist $1,119,187 5% · 1 practitioner
  3. Urology $532,286 2% · 1 practitioner
  4. Anesthesiology $464,562 2% · 2 practitioners
  5. Endocrinology, Diabetes & Metabolism Internal Medicine $434,857 2% · 103 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $38,775,346 97% · 40 recipients
  2. New York $663,808 2% · 9 recipients
  3. Massachusetts $348,165 <1% · 2 recipients
  4. Texas $43,572 <1% · 25 recipients
  5. Florida $41,262 <1% · 6 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

216 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record